TNF‐α‐Induced NOD2 and RIP2 Contribute to the Up‐Regulation of Cytokines Induced by MDP in Monocytic THP‐1 Cells

Abstract

Nucleotide-binding oligomerization domain containing 2 (NOD2)-induced signal transduction and cytokine production is regulated by a number of factors. However, the feedback effect of the pro-inflammatory TNF-α on NOD2-induced inflammation is not fully understood. In this study, we found unexpectedly that TNF-α up-regulated NOD2 ligand MDP-induced production of the CXC chemokines, including CXCL1, 2, and 8, and the pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α, in a dose-dependent manner at both mRNA and protein levels in monocytic THP-1 cells. Though TNF-α induced the up-regulation of ubiquitin-editing enzyme A20, an important negative regulator for Toll-like receptor- and NOD2-induced inflammatory responses, the over-expression of A20 by gene transfer did not reversed MDP-induced production of cytokines, suggested that A20 did not regulate the functions of NOD2 in THP-1 cells. Meanwhile, we found that TNF-α up-regulated NOD2 and its down-stream adaptor protein RIP2 at both mRNA and protein levels. MDP induced the activation of ERK, JNK, p38 and NF-κB, and TNF-α pre-treatment augmented this activation. The results from pharmacological inhibition assay showed that cytokine production was dependent on MAPK signaling. In addition, we found that the pre-treatment of THP-1 cells with MDP down-regulated the mRNA levels of cytokine induced by MDP re-treatment. MDP pre-treatment up-regulated NOD2, but down-regulated RIP2, and down-regulated NOD2 signal transduction induced by MDP re-stimulation. Taking together, these results suggested that TNF-α is a positive regulator for NOD2 functions via up-regulation of NOD2 and its signal adaptor RIP2, and TNF-α-induced A20 does not regulate MDP-induced inflammatory responses in THP-1 cells. J. Cell. Biochem. 119: 5072-5081, 2018. © 2017 Wiley Periodicals, Inc.

Comprehensive multiomic profiling of somatic mutations in malformations of cortical development

“…4a), likely reflecting shared neuropathological features that include large dysplastic neurons. As expected, FCT Type IIA, Type IIB, and HME were positively associated with the mTOR pathway GO term and COSMIC DB entry, FCD Type III, however, was associated with the MAPK pathway, consistent with recent publications implicating BRAF, FGFR2, NOD2 , and MAPK9 in their etiology 34–36 . FCD Type I showed few strong positive correlations except for Glycosylation, consistent with recent associations with SLC35A2 and CANT1 37,38 .…”

IAPs Regulate Distinct Innate Immune Pathways to Co-ordinate the Response to Bacterial Peptidoglycans

“…Thus, rather than TNF signaling taking over from NOD2, this suggests that it may contribute to cytokine production by sustaining the NOD2 signal. This conclusion is in line with data showing that NOD2 and RIPK2 may be upregulated by TNF (Chen et al, 2017).…”

Synergistic interactions between NOD receptors and TLRs: Mechanisms and clinical implications

“…This cross‐regulation could be direct or mediated by autocrine and/or paracrine mechanisms. For example, NOD1, NOD2, and RIP2 genes are regulated by NF‐κB, and their expression is augmented by different TLR agonists . LPS induces a two‐waive up‐regulation of NOD1 and NOD2 mRNA expression in RAW264.7 cells, the first waive being mediated by NF‐κB activation directly downstream of TLR4, and the second waive by autocrine TNF .…”